← Eichor
Study identifier: NCT06208917 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

Condition: Pediatric Solid Tumor, Unspecified, Protocol Specific  ·  Sponsor: Yizhuo Zhang

PhasePhase 3
Planned participants376
Who can joinAll sexes, 6 Months to 18 Years
Healthy volunteersNo

About this study

The purpose is to evaluate the efficacy of ondansetron oral soluble film plus dexamethasone in preventing chemotherapy-induced nausea and vomiting (CINV) with MEC/HEC chemotherapy in children with solid tumor.

This description comes directly from the study's public registry record.

Talk to the study team

Yizhuo Zhang  ·  +86 87342460  ·  zhangyzh@sysucc.org.cn

Yizhuo Zhang  ·  +8687342460  ·  zhangyzh@sysucc.org.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Sun Yat-sen University Cancer CenterGuangzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06208917